drugset / Trial / NCT04740814
A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
NaSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to evaluate the pharmacokinetics and safety of certolizumab pegol in adults with active rheumatoid arthritis.
Timeline
- Start
- 2021-02-11
- Primary completion
- 2022-01-24
- Completion
- 2022-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Certolizumab Pegol | Protein / enzyme biologic | — | Subcutaneous |